Theratechnologies Preço/Valor Contábil
Qual é o Preço/Valor Contábil de Theratechnologies?
O Preço/Valor Contábil de Theratechnologies, Inc. é -4.52
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em TSX em comparação com Theratechnologies
O que Theratechnologies faz?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Empresas com preço/valor contábil semelhantes a Theratechnologies
- Dine Brands Global Inc tem Preço/Valor Contábil de -4.56
- Intact Gold tem Preço/Valor Contábil de -4.55
- Sculptor Capital Management tem Preço/Valor Contábil de -4.54
- Predilife S.A tem Preço/Valor Contábil de -4.54
- The Bombay Dyeing and Manufacturing tem Preço/Valor Contábil de -4.53
- Sealand Capital Galaxy tem Preço/Valor Contábil de -4.53
- Theratechnologies tem Preço/Valor Contábil de -4.52
- Austral Resources Australia tem Preço/Valor Contábil de -4.52
- Jia limited tem Preço/Valor Contábil de -4.50
- Symbol Mining tem Preço/Valor Contábil de -4.49
- Orosur Mining tem Preço/Valor Contábil de -4.48
- Yum! Brands tem Preço/Valor Contábil de -4.46
- Rhinomed tem Preço/Valor Contábil de -4.46